eGnome has signed a deal to transfer its NGS microbiome diagnostic technology to Fraumed in Japan. This agreement aims to enhance eGnome's presence in the Japanese market and provide advanced diagnostic solutions. The technology transfer is expected to improve healthcare outcomes by offering precise microbiome analysis and targeted interventions.